Colony Bankcorp Earnings Calls
| Release date | Apr 22, 2026 |
| EPS estimate | $0.450 |
| EPS actual | $0.450 |
| Revenue estimate | 40.2M |
| Revenue actual | 39.895M |
| Revenue Surprise | -0.759% |
| Release date | Jan 28, 2026 |
| EPS estimate | $0.460 |
| EPS actual | $0.480 |
| EPS Surprise | 4.35% |
| Revenue estimate | 36.4M |
| Revenue actual | 36.912M |
| Revenue Surprise | 1.41% |
| Release date | Oct 22, 2025 |
| EPS estimate | $0.470 |
| EPS actual | $0.470 |
| Revenue estimate | 37.8M |
| Revenue actual | 32.79M |
| Revenue Surprise | -13.25% |
| Release date | Jul 23, 2025 |
| EPS estimate | $0.400 |
| EPS actual | $0.460 |
| EPS Surprise | 15.00% |
| Revenue estimate | 33.6M |
| Revenue actual | 32.483M |
| Revenue Surprise | -3.32% |
Last 4 Quarters for Colony Bankcorp
Below you can see how CBAN performed 4 days prior and 4 days after releasing the earnings report. Also, you can see the pre-estimates and the actual earnings. This information can give you a slight idea of what you might expect for the next quarter's release.
| Release date | Jul 23, 2025 |
| Price on release | $17.80 |
| EPS estimate | $0.400 |
| EPS actual | $0.460 |
| EPS surprise | 15.00% |
| Date | Price |
|---|---|
| Jul 17, 2025 | $17.67 |
| Jul 18, 2025 | $17.52 |
| Jul 21, 2025 | $17.62 |
| Jul 22, 2025 | $17.73 |
| Jul 23, 2025 | $17.80 |
| Jul 24, 2025 | $16.74 |
| Jul 25, 2025 | $16.54 |
| Jul 28, 2025 | $16.52 |
| Jul 29, 2025 | $16.62 |
| 4 days before | 0.736% |
| 4 days after | -6.63% |
| On release day | -5.96% |
| Change in period | -5.94% |
| Release date | Oct 22, 2025 |
| Price on release | $16.74 |
| EPS estimate | $0.470 |
| EPS actual | $0.470 |
| Date | Price |
|---|---|
| Oct 16, 2025 | $15.96 |
| Oct 17, 2025 | $16.09 |
| Oct 20, 2025 | $16.35 |
| Oct 21, 2025 | $16.56 |
| Oct 22, 2025 | $16.74 |
| Oct 23, 2025 | $16.31 |
| Oct 24, 2025 | $16.70 |
| Oct 27, 2025 | $16.54 |
| Oct 28, 2025 | $16.37 |
| 4 days before | 4.89% |
| 4 days after | -2.21% |
| On release day | -2.57% |
| Change in period | 2.57% |
| Release date | Jan 28, 2026 |
| Price on release | $18.56 |
| EPS estimate | $0.460 |
| EPS actual | $0.480 |
| EPS surprise | 4.35% |
| Date | Price |
|---|---|
| Jan 22, 2026 | $19.50 |
| Jan 23, 2026 | $18.65 |
| Jan 26, 2026 | $18.59 |
| Jan 27, 2026 | $18.51 |
| Jan 28, 2026 | $18.56 |
| Jan 29, 2026 | $19.48 |
| Jan 30, 2026 | $19.46 |
| Feb 02, 2026 | $20.11 |
| Feb 03, 2026 | $20.51 |
| 4 days before | -4.82% |
| 4 days after | 10.51% |
| On release day | 4.96% |
| Change in period | 5.18% |
| Release date | Apr 22, 2026 |
| Price on release | $20.81 |
| EPS estimate | $0.450 |
| EPS actual | $0.450 |
| Date | Price |
|---|---|
| Apr 16, 2026 | $20.79 |
| Apr 17, 2026 | $21.25 |
| Apr 20, 2026 | $21.23 |
| Apr 21, 2026 | $20.62 |
| Apr 22, 2026 | $20.81 |
| Apr 23, 2026 | $19.98 |
| Apr 24, 2026 | $19.89 |
| Apr 27, 2026 | $19.96 |
| Apr 28, 2026 | $20.12 |
| 4 days before | 0.0962% |
| 4 days after | -3.32% |
| On release day | -3.99% |
| Change in period | -3.22% |
Colony Bankcorp Earnings Call Transcript Summary of Q1 2026
Colony Bancorp completed its core systems conversion and customer integration from the TC Federal merger, delivering a solid start to 2026. Operating net income was $9.5 million with operating pre‑provision net revenue of $13.9 million. Net interest margin expanded to 3.48% (core margin ~3.41%), helped by accelerated accretion income from acquired loans; management expects margin to normalize a few basis points lower in Q2. Loan growth was muted in Q1 due to early payoffs and lighter demand; management reiterates a 2026 loan growth target nearer the low end of guidance (~8%). Credit quality improved quarter‑over‑quarter (NPLs and criticized/classified loans declined) and the allowance remains healthy (0.90% of loans, 122% of NPLs). Complementary business lines showed strength: mortgage production and pretax income improved, Colony Financial Advisors AUM grew to $555 million, and insurance and merchant services showed meaningful progress. Operating noninterest expense was $26.0 million (operating net NIE to assets 1.68%) with merger-related costs largely behind them; management expects expense leverage and targets a 1.45% net noninterest expense ratio over the next several quarters. The board approved share repurchases (~89k shares at $19.78 this quarter) and declared a $0.12 quarterly dividend. Kroll affirmed ratings with a stable outlook. Management remains active on M&A, focused on strategic, cultural fits in Georgia and contiguous states.
Sign In
Buy CBAN